Publications

• Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen
  Chan, L. S., Lapiere, J. C., Chen, M., Traczyk, T., Mancini, A. J., Paller, A. S., … Marinkovich, M. P. (1999). Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. ARCHIVES OF DERMATOLOGY, 135(5), 569–73.
• BP180 gene delivery in junctional epidermolysis bullosa
  Seitz, C. S., Giudice, G. J., Balding, S. D., Marinkovich, M. P., & Khavari, P. A. (1999). BP180 gene delivery in junctional epidermolysis bullosa. GENE THERAPY, 6(1), 42–47.
• Gene therapy for a lethal genetic blistering disease: a status report.
  BAUER, E. A., Herron, G. S., Marinkovich, M. P., Khavari, P. A., & Lane, A. T. (1999). Gene therapy for a lethal genetic blistering disease: a status report. Transactions of the American Clinical and Climatological Association, 110, 86–92.
• Melanocytes adhere to and synthesize laminin-5 in vitro Scott, G. A., Cassidy, L., Tran, H., Rao, S. K., & Marinkovich, M. P. (1999). Melanocytes adhere to and synthesize laminin-5 in vitro. EXPERIMENTAL DERMATOLOGY, 8(3), 212–21.
  
• Update on inherited bullous dermatoses Marinkovich, M. P. (1999). Update on inherited bullous dermatoses. DERMATOLOGIC CLINICS, 17(3), 473-?
  
• Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2) Olivry, T., Chan, L. S., Xu, L., Chace, P., Dunston, S. M., Fahey, M., & Marinkovich, M. P. (1999). Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2). VETERINARY PATHOLOGY, 36(4), 328–35.
  
• Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa Olivry, T., Dunston, S. M., & Marinkovich, M. P. (1999). Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa. VETERINARY PATHOLOGY, 36(6), 616–618.
  
• Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa Pulkkinen, L., Marinkovich, M. P., Tran, H. T., Lin, L., Herron, G. S., & Uitto, J. (1999). Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 113(6), 1114–18.
  
• Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen Kawahara, Y., Zillikens, D., Yancey, K. B., Marinkovich, M. P., Nie, Z., Hashimoto, T., & Nishikawa, T. (2000). Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. JOURNAL OF DERMATOLOGICAL SCIENCE, 23(2), 93–102.
  
• Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans Olivry, T., Dunston, S. M., Fahey, M., Nguyen, N., & Marinkovich, M. P. (2000). Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans. VETERINARY PATHOLOGY, 37(4), 302–9.
  
• Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding Areida, S. K., Reinhardt, D. P., Muller, P. K., FIETZEK, P. P., Kowitz, J., Marinkovich, M. P., & Notbohm, H. (2001). Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(2), 1594–1601.
  
• Laminins and human disease McGowan, K. A., & Marinkovich, M. P. (2000). Laminins and human disease. MICROSCOPY RESEARCH AND TECHNIQUE, 51(3), 262–79.
  
• Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes Schmidt, E., Reimer, S., Kruse, N., Jainta, S., Brocker, E. B., Marinkovich, M. P., … Zillikens, D. (2000). Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 115(5), 842–48.
  
• IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain Egan, C. A., Reddy, E. D., Nie, Z. X., Taylor, T. B., Schmidt, L. A., Meyer, L. J., … Zone, J. J. (2001). IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 116(2), 348–50.
  
• A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions Olivry, T., Dunston, S. M., Schachter, M., Xu, L. T., Nguyen, N., Marinkovich, M. P., & Chan, L. S. (2001). A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. JOURNAL OF AUTOIMMUNITY, 16(4), 411–21.
  
• Linear IgA bullous dermatosis Guide, S. V., & Marinkovich, M. P. (2001). Linear IgA bullous dermatosis. CLINICS IN DERMATOLOGY, 19(6), 719–27.
  
• The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators Chan, L. S., Ahmed, A. R., ANHALT, G. J., Bernauer, W., Cooper, K. D., Elder, M. J., … Zone, J. J. (2002). The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. ARCHIVES OF DERMATOLOGY, 138(3), 370–79.
  
• Epidermolysis bullosa: new and emerging trends. Pai, S., & Marinkovich, M. P. (2002). Epidermolysis bullosa: new and emerging trends. American Journal of Clinical Dermatology, 3(6), 371–80.
  
• Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin Veitch, D. P., Nokelainen, P., McGowan, K. A., Nguyen, T. T., Nguyen, N. E., Stephenson, R., … Marinkovich, P. M. (2003). Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 278(18), 15661–68.
  
• Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue Ortiz-Urda, S., Lin, Q., Green, C. L., Keene, D. R., Marinkovich, M. P., & Khavari, P. A. (2003). Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. JOURNAL OF CLINICAL INVESTIGATION, 111(2), 251–55.
  
• NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., … Khavari, P. A. (2003). NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia. NATURE, 421(6923), 639–43.
  
• Laminin-10 is crucial for hair morphogenesis Li, J., Tzu, J., Chen, Y., Zhang, Y. P., Nguyen, N. T., Gao, J., … Marinkovich, M. P. (2003). Laminin-10 is crucial for hair morphogenesis. EMBO JOURNAL, 22(10), 2400–2410.
  
• Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid Chu, J., Bradley, M., & Marinkovich, M. P. (2003). Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. ARCHIVES OF DERMATOLOGY, 139(6), 813–15.
  
• alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin Russell, A. J., Fincher, E. F., Millman, L., Smith, R., Vela, V., Waterman, E. A., … Marinkovich, M. P. (2003). alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. JOURNAL OF CELL SCIENCE, 116(17), 3543–56.
  
• Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Meneguzzi, G., Marinkovich, M. P., Aberdam, D., Pisani, A., Burgeson, R., & Ortonne, J. P. (1992). Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Experimental Dermatology, 1(5), 221–229.
  
• THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT Marinkovich, M. P., Lunstrum, G. P., Keene, D. R., & Burgeson, R. E. (1992). THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT. JOURNAL OF CELL BIOLOGY, 119(3), 695–703.
  
• IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN Lunstrum, G. P., McDonough, A. M., Marinkovich, M. P., Keene, D. R., Morris, N. P., & Burgeson, R. E. (1992). IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(28), 20087–20092.
  
• Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors Zahir, N., Lakins, J. N., Russell, A., Ming, W. Y., Chatterjee, C., Rozenberg, G. I., … Weaver, V. M. (2003). Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors. JOURNAL OF CELL BIOLOGY, 163(6), 1397–1407.
  
• Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44 Vivinus-Nebot, M., Rousselle, P., Breittmayer, J. P., Cenciarini, C., Berrih-Aknin, S., Spong, S., … Bernard, A. (2004). Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44. JOURNAL OF IMMUNOLOGY, 172(3), 1397–1406.
  
• Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis Chang, H. Y., Cooper, Z. A., Swetter, S. A., & Marinkovich, M. P. (2004). Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis. ARCHIVES OF DERMATOLOGY, 140(2), 242–44.
  
• THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR Marinkovich, M. P., Lunstrum, G. P., & Burgeson, R. E. (1992). THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(25), 17900–17906.
  
• Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma Arbiser, J. L., Fan, C. Y., Su, X. B., van Emburgh, B. O., Cerimele, F., Miller, M. S., … Marinkovich, M. P. (2004). Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 123(4), 788–90.
  
• Type VII collagen is required for Ras-driven human epidermal tumorigenesis Ortiz-Urda, S., Garcia, J., Green, C. L., Chen, L., Lin, Q., Veitch, D. P., … Khavari, P. A. (2005). Type VII collagen is required for Ras-driven human epidermal tumorigenesis. SCIENCE, 307(5716), 1773–76.
  
• A simplified laminin nomenclature Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., Ekblom, P., … Yurchenco, P. D. (2005). A simplified laminin nomenclature. MATRIX BIOLOGY, 24(5), 326–32.
  
• Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions Li, J., Zhou, L., Tran, H. T., Chen, Y., Nguyen, N. E., Karasek, M. A., & Marinkovich, M. P. (2006). Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126(2), 432–40.
  
• beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1 Pullar, C. E., Baier, B. S., Kariya, Y., Russell, A. J., Horst, B. A. J., Marinkovich, M. P., & Isseroff, R. R. (2006). beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. MOLECULAR BIOLOGY OF THE CELL, 17(11), 4925–35.
  
• Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells Culp, T. D., Budgeon, L. R., Marinkovich, M. P., Meneguzzi, G., & Christensen, N. D. (2006). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. JOURNAL OF VIROLOGY, 80(18), 8940–50.
  
• Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization Sehgal, B. U., DeBiase, P. J., Matzno, S., Chew, T.-L., Claiborne, J. N., Hopkinson, S. B., … Jones, J. C. R. (2006). Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. JOURNAL OF BIOLOGICAL CHEMISTRY, 281(46), 35487–98.
  
• Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Marinkovich, M. P. (2007). Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nature Reviews. Cancer, 7(5), 370–80.
  
• A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation Waterman, E. A., Sakai, N., Nguyen, N. T., Horst, B. A. J., Veitch, D. P., Dey, C. N., … Marinkovich, M. P. (2007). A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. CANCER RESEARCH, 67(9), 4264–70.
  
• What's new in blistering disorders? Chaudbari, P., & Marinkovich, M. P. (2007). What's new in blistering disorders? CURRENT ALLERGY AND ASTHMA REPORTS, 7(4), 255–63.
  
• Bridging structure with function: Structural, regulatory, and developmental role of laminins Tzu, J., & Marinkovich, M. P. (2008). Bridging structure with function: Structural, regulatory, and developmental role of laminins. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 40(2), 199–214.
  
• Targeting a tumor-specific laminin domain critical for human carcinogenesis Tran, M., Rousselle, P., Nokelainen, P., Tallapragada, S., Nguyen, N. T., Fincher, E. F., & Marinkovich, M. P. (2008). Targeting a tumor-specific laminin domain critical for human carcinogenesis. CANCER RESEARCH, 68(8), 2885–94.
  
• Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis Gao, J., DeRouen, M. C., Chen, C.-H., Nguyen, M., Nguyen, N. T., Ido, H., … Marinkovich, M. P. (2008). Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. GENES & DEVELOPMENT, 22(15), 2111–24.
  
• Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies Nguyen, B., Dusek, R. L., Beaudry, V. G., Marinkovich, M. P., & Attardi, L. D. (2009). Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(7), 1710–18.
  
• Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders Ko, M. S., & Marinkovich, M. P. (2010). Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders. DERMATOLOGIC CLINICS, 28(1), 1-?
  
• Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules Sakai, N., Waterman, E. A., Nguyen, N. T., Keene, D. R., & Marinkovich, M. P. (2010). Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(8), 2147–50.
  
• Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue Siprashvili, Z., Nguyen, N. T., Bezchinsky, M. Y., Marinkovich, M. P., Lane, A. T., & Khavari, P. A. (2010). Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue. HUMAN GENE THERAPY, 21(10), 1299–1310.
  
• Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation DeRouen, M. C., Zhen, H., Tan, S. H., Williams, S., Marinkovich, M. P., & Oro, A. E. (2010). Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. BMC DEVELOPMENTAL BIOLOGY, 10.
  
• Discovery of basement membrane components. Marinkovich, M. P. (2008). Discovery of basement membrane components. Journal of Investigative Dermatology, 128(E2), E3–4.
  
• Molecular organization of the basement membrane zone Hashmi, S., & Marinkovich, M. P. (2011). Molecular organization of the basement membrane zone. CLINICS IN DERMATOLOGY, 29(4), 398–411.
  
• Linear immunoglobulin A bullous dermatosis Fortuna, G., & Marinkovich, M. P. (2012). Linear immunoglobulin A bullous dermatosis. CLINICS IN DERMATOLOGY, 30(1), 38–50.
  
• A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity? Fortuna, G., Cesar Salas-Alanis, J., Guidetti, E., & Marinkovich, M. P. (2012). A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity? JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 66(6), 988–94.
  
• Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment. Fortuna, G., Chainani-Wu, N., Lozada-Nur, F., Aria, M., Cepeda-Valdes, R., Pollio, A., … Salas-Alanís, J. C. (2013). Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment. Journal of the American Academy of Dermatology, 68(1), 83–92.
  
• Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications Sun, W., Araci, Z., Inayathullah, M., Manickam, S., Zhang, X., Bruce, M. A., … Butte, M. J. (2013). Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications. ACTA BIOMATERIALIA, 9(8), 7767–74.
  
• SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION Hom, Y. K., Marinkovich, M. P., Lozano, J. J., & Rocha, V. (1989). SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION. CELL CALCIUM, 10(3), 135–144.
  
• BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING Rocha, V., Hom, Y. K., & Marinkovich, M. P. (1986). BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING. EXPERIMENTAL CELL RESEARCH, 165(2), 450–460.
  
• COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS Marinkovich, M. P., & Rocha, V. (1986). COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS. JOURNAL OF CELLULAR PHYSIOLOGY, 128(1), 61–70.
  
• ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5 Kirtschig, G., Marinkovich, M. P., Burgeson, R. E., & Yancey, K. B. (1995). ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(4), 543–548.
  
• A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5 Chan, L. S., Wang, X. S., Lapiere, J. C., Marinkovich, M. P., Jones, J. C. R., & Woodley, D. T. (1995). A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(1), 75–79.
  
• NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE Marinkovich, M. P., Botella, R., DATLOFF, J., & Sangueza, O. P. (1995). NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 32(4), 604–9.
  
• THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES Marinkovich, M. P. (1993). THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES. ARCHIVES OF DERMATOLOGY, 129(12), 1557–65.
  
• CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE Marinkovich, M. P., Keene, D. R., RIMBERG, C. S., & Burgeson, R. E. (1993). CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE. DEVELOPMENTAL DYNAMICS, 197(4), 255–67.
  
• BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL Marinkovich, M. P., Verrando, P., Keene, D. R., Meneguzzi, G., Lunstrum, G. P., Ortonne, J. P., & Burgeson, R. E. (1993). BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL. LABORATORY INVESTIGATION, 69(3), 295–99.
  
• PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS Marinkovich, M. P., Meneguzzi, G., Burgeson, R. E., BLANCHETBARDON, C., Holbrook, K. A., Smith, L. T., … Ortonne, J. P. (1995). PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS. PRENATAL DIAGNOSIS, 15(11), 1027–34.
  
• LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells Marinkovich, M. P., Taylor, T. B., Keene, D. R., Burgeson, R. E., & Zone, J. J. (1996). LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 734–38.
  
• A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(3), 465–70.
  
• A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. Journal of Investigative Dermatology, 106(6), 1333–1338.
  
• Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin Chen, M., Marinkovich, M. P., Veis, A., Cai, X. Y., Rao, C. N., OToole, E. A., & Woodley, D. T. (1997). Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(23), 14516–22.
  
• Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., Chen, M., … Marinkovich, M. P. (1997). Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(6), 848–53.
  
• Laminin-5 inhibits human keratinocyte migration OToole, E. A., Marinkovich, M. P., Hoeffler, W. K., FURTHMAYR, H., & Woodley, D. T. (1997). Laminin-5 inhibits human keratinocyte migration. EXPERIMENTAL CELL RESEARCH, 233(2), 330–39.
  
• LAD-1 is absent in a subset of junctional epidermolysis bullosa patients Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., Jonkman, M. F., … BRUCKNERTUDERMAN, L. (1997). LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 109(3), 356–59.
  
• Immunodissection of the connective tissue matrix in human skin Keene, D. R., Marinkovich, M. P., & Sakai, L. Y. (1997). Immunodissection of the connective tissue matrix in human skin. MICROSCOPY RESEARCH AND TECHNIQUE, 38(4), 394–406.
  
• Hypoxia increases human keratinocyte motility on connective tissue O'Toole, E. A., Marinkovich, M. P., Peavey, C. L., Amieva, M. R., FURTHMAYR, H., Mustoe, T. A., & Woodley, D. T. (1997). Hypoxia increases human keratinocyte motility on connective tissue. JOURNAL OF CLINICAL INVESTIGATION, 100(11), 2881–91.
  
• Self-assembly of laminin isoforms Cheng, Y. S., Champliaud, M. F., Burgeson, R. E., Marinkovich, M. P., & Yurchenco, P. D. (1997). Self-assembly of laminin isoforms. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(50), 31525–32.
  
• NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats Chen, M., Marinkovich, M. P., Jones, J. C. R., O'Toole, E. A., Li, Y. Y., & Woodley, D. T. (1999). NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(2), 177–83.
  
• Activation of the small GTPase Rac1 alters localization of integrin alpha 3 beta 1 leading to disruption of Hemidesmosome formation Chu, J., Russell, A. J., & Marinkovich, M. P. (2002). Activation of the small GTPase Rac1 alters localization of integrin alpha 3 beta 1 leading to disruption of Hemidesmosome formation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 229–29.
  
• Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., Keene, D. R., … Senior, R. M. (2012). Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice. PLOS ONE, 7(9).
  
• Human microvascular endothelial cells produce a novel laminin variant. Tran, H. H., Rao, S. K., Zhang, D. N., Romero, L., Khush, K., Herron, G. S., & Marinkovich, M. P. (1996). Human microvascular endothelial cells produce a novel laminin variant. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 143–43.
  
• Laminins 8 and 10 in skin basement membrane reconstitution and wound healing Li, J., Zhu, L., Kirsner, R. S., Davis, S. C., Mertz, P. M., Eaglstein, W. H., … Zhang, Y. (2004). Laminins 8 and 10 in skin basement membrane reconstitution and wound healing. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A31–A31.
  
• Processing of laminin-5 in keratinocyte migration Veitch, D. P., McGowan, K., Findell, P., Sharma, P., & Marinkovich, M. P. (2000). Processing of laminin-5 in keratinocyte migration. AMER SOC CELL BIOLOGY.
  
• Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice. Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., Keene, D. R., … Senior, R. M. (2012). Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice. PloS One, 7(9).
  
• Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model Liu, Z., Sui, W., Zhao, M., Li, Z., Li, N., Thresher, R., … Diaz, L. A. (2008). Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. JOURNAL OF AUTOIMMUNITY, 31(4), 331–38.
  
• Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies Olivry, T., Bizikova, P., Dunston, S. M., Bond, R., Halliwell, R., Loeffler, A., … Marinkovich, M. P. (2010). Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies. VETERINARY DERMATOLOGY, 21(4), 345–57.
  
• Multiple functions for beta 4 integrin in human microvascular endothelial cells Marinkovich, M., Zhou, L., Russell, A., Li, J., & Karasek, M. (2001). Multiple functions for beta 4 integrin in human microvascular endothelial cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 391–91.
  
• A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone (vol 106, pg 465, 1996) Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone (vol 106, pg 465, 1996). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(6), 1332–38.
  
• BP180 gene transfer and expression in benign junctional epidermolysis bullosa. Seitz, C. S., Marinkovich, M. P., Tran, H., Janoff, M., Diaz, L. A., OToole, E. A., … Khavari, P. A. (1997). BP180 gene transfer and expression in benign junctional epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 305–.
  
• LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., Jonkman, M. F., … BRUCKNERTUDERMAN, L. (1996). LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 281–81.
  
• Laminin-5 is synthesized by normal human melanocytes, but not melanoma cells, and is a ligand for melanocytes in vivo. Scott, G. A., Cassidy, L., Tran, H. H., Rao, S. K., & Marinkovich, M. P. (1996). Laminin-5 is synthesized by normal human melanocytes, but not melanoma cells, and is a ligand for melanocytes in vivo. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 130–30.
  
• Laminin-B is a lamina, densa autoantigen ih oral pemphigoid. Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., Chen, M., … Marinkovich, M. P. (1996). Laminin-B is a lamina, densa autoantigen ih oral pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 41–41.
  
• Identification of multiple, distinct cicatritial pemphigoid autoantigens. Rao, S. K., Tran, H. H., Allen, J., Wojnarowska, F., & Marinkovich, M. P. (1996). Identification of multiple, distinct cicatritial pemphigoid autoantigens. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 39–39.
  
• LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180. Tran, H. H., Schumann, H., Balding, S., Giudice, G. J., BRUCKNERTUDERMAN, L., & Marinkovich, M. P. (1997). LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 289–89.
  
• Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion Tran, M. M., Rousselle, P., Nokelainen, P., Nguyen, N., Keene, D. R., Fincher, E. F., & Marinkovich, M. P. (2006). Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion. Presented at the 67th Annual Meeting of the Society-for-Investigative-Dermatology, PHILADELPHIA,PA,PA,PA,PA,PA,PA: NATURE PUBLISHING GROUP.
  
• Observations of epidermal grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules Sakai, N., Waterman, E., Nguyen, N., Keene, D., Kawana, S., & Marinkovich, M. P. (2008). Observations of epidermal grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules. Presented at the International Investigative Dermatology Meeting, KYOTO,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN: NATURE PUBLISHING GROUP.
  
• Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis Ortiz-Urda, S., Garcia, J., Marinkovich, M., & Khavari, P. (2005). Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A25–A25.
  
• Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression Horst, B. A., Russell, A., Nguyen, N., & Marinkovich, M. P. (2007). Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression. Presented at the 96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, SAN DIEGO,CA,CA,CA,CA,CA,CA: NATURE PUBLISHING GROUP.
  
• Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development Horst, B. A., Nokelainen, P., Fincher, E. F., Nguyen, N. T., Russell, A. J., & Marinkovich, M. P. (2004). Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A19–A19.
  
• A processed laminin-332 domain selectively localizes to and potentiates carcinoma development Tran, M. M., Rousselle, P., Nokelainen, N. P., Talapragada, S., Nguyen, N., & Marinkovich, M. P. (2007). A processed laminin-332 domain selectively localizes to and potentiates carcinoma development. Presented at the 37th Annual Meeting of the European-Society-for-Dermatological-Research, ZURICH,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: NATURE PUBLISHING GROUP.
  
• Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion Waterman, E. A., Ortiz-Urda, S., Nguyen, N. T., Veitch, D. P., Horst, B. A., Dey, C. N., … Marinkovich, M. P. (2005). Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A22–A22.
  
• Laminin 10 is essential for hair development Tzu, J. E., Li, J., Lehman, D., Chen, Y., Nguyen, N. T., Keene, D. R., … Marinkovich, M. (2002). Laminin 10 is essential for hair development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 291–91.
  
• Targeting a tumor specific laminin domain critical for human carcinogenesis Tran, M. M., Rousselle, P., Tallapragracku, S., Nguyen, N., & Marinkovich, M. P. (2008). Targeting a tumor specific laminin domain critical for human carcinogenesis. Presented at the International Investigative Dermatology Meeting, KYOTO,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN: NATURE PUBLISHING GROUP.
  
• Identification of binding sites of noncollagenous (NCl) domain of type VII collagen with laminin 5/6 and other extracellular matrix components. Chen, M., Marinkovich, M. P., Cai, X. Y., & Woodley, D. T. (1997). Identification of binding sites of noncollagenous (NCl) domain of type VII collagen with laminin 5/6 and other extracellular matrix components. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 461–61.
  
• Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa Tolar, J., Xia, L., Lees, C. J., Riddle, M., McElroy, A., Keene, D. R., … Wagner, J. E. (2013). Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133(2), 562–65.
  
• Diagnosing Epidermolysis Bullosa Type and Subtype in Infancy Using Immunofluorescence Microscopy: The Stanford Experience Berk, D. R., Jazayeri, L., Marinkovich, M. P., Sundram, U. N., & Bruckner, A. L. (2013). Diagnosing Epidermolysis Bullosa Type and Subtype in Infancy Using Immunofluorescence Microscopy: The Stanford Experience. PEDIATRIC DERMATOLOGY, 30(2), 226–33.
  
• Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology Fortuna, G., Lozada-Nur, F., Pollio, A., Aria, M., Cepeda-Valdes, R., Marinkovich, M. P., … Cesar Salas-Alanis, J. (2013). Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 42(10), 733–40.
  
• A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa Venugopal, S. S., Yan, W., Frew, J. W., Cohn, H. I., Rhodes, L. M., Kim Tran, K., … Murrell, D. F. (2013). A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 69(6), 898–915.
  
• Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant. Melo, S. P., Lisowski, L., Bashkirova, E., Zhen, H. H., Chu, K., Keene, D. R., … Oro, A. E. (2014). Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant. Molecular Therapy : the Journal of the American Society of Gene Therapy, 22(4), 725–33.
  
• Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification Fine, J.-D., Bruckner-Tuderman, L., Eady, R. A. J., Bauer, E. A., Bauer, J. W., Has, C., … Zambruno, G. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(6), 1103–26.
  
• Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals Olivry, T., & Marinkovich, M. P. (2002). Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals. Presented at the 4th World Conference of Veterinary Dermatology, SAN FRANCISCO,CA: BLACKWELL SCIENCE PUBL.
  
• Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. Fine, J.-D., Bruckner-Tuderman, L., Eady, R. A. J., Bauer, E. A., Bauer, J. W., Has, C., … Zambruno, G. (2014). Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. Journal of the American Academy of Dermatology, 70(6), 1103–26.
  
• Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. Fortuna, G., Lozada-Nur, F., Pollio, A., Aria, M., Cepeda-Valdes, R., Marinkovich, M. P., … Salas-Alanís, J. C. (2013). Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. Journal of Oral Pathology & Medicine , 42(10), 733–40.
  
• Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts Murrell, D. F., Marinovic, B., Caux, F., Prost, C., Ahmed, R., Wozniak, K., … Werth, V. P. (2015). Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(1), 168–74.
  
• Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles Sun, W., Inayathullah, M., Manoukian, M. A. C., Malkovskiy, A. V., Manickam, S., Marinkovich, M. P., … Rajadas, J. (2015). Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles. ANNALS OF BIOMEDICAL ENGINEERING, 43(12), 2978–90.
  
• RAC1 activation drives pathologic interactions between the epidermis and immune cells Winge, M. C. C., Ohyama, B., Dey, C. N., Boxer, L. M., Li, W., Ehsani-Chimeh, N., … Marinkovich, M. P. (2016). RAC1 activation drives pathologic interactions between the epidermis and immune cells. JOURNAL OF CLINICAL INVESTIGATION, 126(7), 2661–77.
  
• Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Khuu, P., Furukawa, L. K., … Marinkovich, M. P. (2016). Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA, 316(17), 1808–17.
  
• Practice and Educational Gaps in Blistering Disease Ehsani-Chimeh, N., & Marinkovich, M. P. (2016). Practice and Educational Gaps in Blistering Disease. DERMATOLOGIC CLINICS, 34(3), 251-?
  
• Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. Kennedy Crispin, M., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight, 1(15).
  
• Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment Fortuna, G., Chainani-Wu, N., Lozada-Nur, F., Aria, M., Cepeda-Valdes, R., Pollio, A., … Cesar Salas-Alanis, J. (2013). Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 68(1), 83–92.
  
• Microtubules acquire resistance from mechanical breakage through intralumenal acetylation Xu, Z., Schaedel, L., Portran, D., Aguilar, A., Gaillard, J., Marinkovich, M. P., … Nachury, M. V. (2017). Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. SCIENCE, 356(6335), 328–32.
  
• BMP1-like proteinases are essential to the structure and wound healing of skin Muir, A. M., Massoudi, D., Ngon Nguyen, N., Keene, D. R., Lee, S.-J., Birk, D. E., … Greenspan, D. S. (2016). BMP1-like proteinases are essential to the structure and wound healing of skin. MATRIX BIOLOGY, 56, 114–31.
  
• Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen. Hayakawa, T., Hirako, Y., Teye, K., Tsuchisaka, A., Koga, H., Ishii, N., … Hashimoto, T. (2017). Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen. Experimental Dermatology.
  
• Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn. Heinecke, G., Marinkovich, M. P., & Rieger, K. E. (2017). Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn. Pediatric Dermatology, 34(3), 308–14.
  
• Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. Woodley, D. T., Cogan, J., Hou, Y., Lyu, C., Marinkovich, M. P., Keene, D., & Chen, M. (2017). Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. The Journal of Clinical Investigation, 127(8), 3028–38.
  
• Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis. Winge, M. C. G., & Marinkovich, M. P. (2017). Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis. Small GTPases, 1–6.
  
• High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Alcántara-Hernández, M., Leylek, R., Wagar, L. E., Engleman, E. G., Keler, T., Marinkovich, M. P., … Idoyaga, J. (2017). High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity.
  
• Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis Marinkovich, M. P. (2018). Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. Chronic Skin Inflammation Accelerates Macrophage Cholesterol Crystal Formation and Atherosclerosis.
  
• Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD Vijayakumar, S., Dang, S., Marinkovich, M. P., Lazarova, Z., Yoder, B., Torres, V. E., & Wallace, D. P. (2014). Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 306(6), F640–F654.
  
• Advances in inherited epidermolysis bullosa. McAllister, J. C., & Peter Marinkovich, M. (2005). Advances in inherited epidermolysis bullosa. Advances in Dermatology, 21, 303–34.
  
• Discovery of Basement Membrane Components. Peter Marinkovich, M. (2008). Discovery of Basement Membrane Components. Journal of Investigative Dermatology, 128, E3–4.
  
• ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis. Fuhriman, J. M., Winge, M. C., Haberstock-Debic, H., Funk, J. O., Bradshaw, J. M., & Marinkovich, M. P. (2018). ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis. The Journal of Investigative Dermatology, 138(4), 864–71.
  
• Validity and Accuracy of a Mobile Phone Application for the Assessment of Wounds in Recessive Dystrophic Epidermolysis Bullosa. Nazaroff, J., Solis, D., Barriga, M., Dutt-Singkh, Y., Shufeng, L., Marinkovich, M. P., & Tang, J. Y. (2017). Validity and Accuracy of a Mobile Phone Application for the Assessment of Wounds in Recessive Dystrophic Epidermolysis Bullosa. Journal of the American Academy of Dermatology.
  
• Type VII Collagen Is the Major Autoantigen for Sub lamina Densa-Type Linear IgA Bullous Dermatosis Tsuchisaka, A., Ohara, K., Ishii, N., Nguyen, N. T., Marinkovich, M. P., & Hashimoto, T. (2015). Type VII Collagen Is the Major Autoantigen for Sub lamina Densa-Type Linear IgA Bullous Dermatosis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135(2), 626–29.
  
• Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB) Hook, K., Tolar, J., McGrath, J., Osborn, M., Keene, D., Riddle, M., … Wagner, J. (2017). Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S52.
  
• Phase I clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes Siprashvili, Z., Nguyen, N. T., Gorell, E., Loutit, K., Khuu, P., Furukawa, L. K., … Marinkovich, M. (2015). Phase I clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135, S72.
  
• Factors That May Promote an Effective Local Research Environment Wang, K., Lee, C. S., Marinkovich, M. P., Chang, H. Y., Oro, A. E., & Khavari, P. A. (2016). Factors That May Promote an Effective Local Research Environment. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136(8), 1529–31.
  
• Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy Gorell, E. S., Nguyen, N., Siprashvili, Z., Marinkovich, M. P., & Lane, A. T. (2015). Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. BRITISH JOURNAL OF DERMATOLOGY, 173(3), 821–23.
  
• Bone morphogenic protein-1 inhibitors block human squamous cell carcinoma invasion in vitro Pai, S., Veitch, D., Ho, W., Fincher, E., Russell, A., Findell, P., & Marinkovich, M. (2001). Bone morphogenic protein-1 inhibitors block human squamous cell carcinoma invasion in vitro. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 398.
  
• Disruption of integrin a6b4 ligand binding through point mutation in human keratinocytes: Effects upon hemidesmosome formation and cell migration Russell, A. J., Ghaed, S. V., & Marinkovich, M. P. (1999). Disruption of integrin a6b4 ligand binding through point mutation in human keratinocytes: Effects upon hemidesmosome formation and cell migration. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(4), 537.
  
• Epidermal Rac1 hyperactivation is a key feature of human psoriasis Winge, M. C., Ohyama, B., Waterman, E. A., Dei, C., Ehsani-Chimeh, N., Li, W., … Marinkovich, M. P. (2014). Epidermal Rac1 hyperactivation is a key feature of human psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, S18.
  
• Therapy for junctional epidermolysis bullosa: Functional assays and a grafted scid mouse animal model Hoffler, W. K., Nelson, C. F., Matsui, C., Marinkovich, M., Mak, L. L., & Wang, C. K. (1996). Therapy for junctional epidermolysis bullosa: Functional assays and a grafted scid mouse animal model. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 10.
  
• JUNCTIONAL EPIDERMOLYSIS-BULLOSA SKIN GRAFTED TO THE SCID MOUSE SHOWS PRESERVATION OF THE DISEASE PHENOTYPE MARINKOVICH, M. P., WOODLEY, D. T., WATANABE, G. L., JENSEN, R. A., CANTRELL, C. F., BANER, E. A., … KIM, Y. H. (1995). JUNCTIONAL EPIDERMOLYSIS-BULLOSA SKIN GRAFTED TO THE SCID MOUSE SHOWS PRESERVATION OF THE DISEASE PHENOTYPE. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 104(4), 603.
  
• Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression Horst, B. A., Russell, A., Nguyen, N., & Marinkovich, M. P. (2007). Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression. MODERN PATHOLOGY, 20, 94A.
  
• Laminin-5 Beta 3 chain promotes epidermal carcinogenesis through type VII collagen binding and pi3k activation Sakai, N., Waterman, E. A., Nguyen, N. E., Horst, B. A., Veitch, D. P., Dey, C. N., … Marinkovich, M. (2006). Laminin-5 Beta 3 chain promotes epidermal carcinogenesis through type VII collagen binding and pi3k activation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126, 24.
  
• Development of a mouse model for linear IgA bullous dermatosis Geng, P., Lin, L., Park, M., Li, N., Shumate, K., Marinkovich, M. P., … Liu, Z. (2013). Development of a mouse model for linear IgA bullous dermatosis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133, S39.
  
• Antibodies to BP180 induce the release of IL-6 and IL-8 from cultured normal human keratinocytes Schmidt, E., Reimer, S., Kruse, N., Brocker, E. B., Marinkovich, M. P., Giudice, G., & Zillikens, D. (1999). Antibodies to BP180 induce the release of IL-6 and IL-8 from cultured normal human keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 113(3), 438.
  
• Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosa Nazaroff, J., Solis, D., Bailey-Healy, I., Barriga, M., Choi, S., Dutt-Singkh, Y., … Tang, J. Y. (2017). Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S36.
  
• Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata Crispin, M. K., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI INSIGHT, 1(15).
  
• Laminin/integrin expression profile in malignant melanoma Wong, K., Marinkovich, M. P., & Horst, B. A. (2008). Laminin/integrin expression profile in malignant melanoma. LABORATORY INVESTIGATION, 88, 103A–104A.
  
• Laminin 10 plays a critical role in the development of normal skin and hair follicles Li, J., Chen, Y., Miner, J., & Marinkovich, M. (2001). Laminin 10 plays a critical role in the development of normal skin and hair follicles. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 426.
  
• Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB) Tolar, J., McGrath, J., Osborn, M., Keene, D., Riddle, M., Hook, K., … Wagner, J. (2017). Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S65.
  
• Laminin-5 inhibits keratinocyte motility OToole, E. A., Marinkovich, M. P., Shervin, N., & Woodley, D. T. (1996). Laminin-5 inhibits keratinocyte motility. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 98.
  
• Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes Siprashvili, Z., Nguyen, N., Gorell, E., Loutit, K., Dutt-Singkh, Y., Nazaroff, J., … Marinkovich, M. (2017). Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S89.
  
• Durable and efficient corrective keratin 14 gene therapy in recessive epidermolysis bullosa simplex (EBS) Pereira, P., Bruckner-Tuderman, L., Zabel, B., & Marinkovich, M. P. (1999). Durable and efficient corrective keratin 14 gene therapy in recessive epidermolysis bullosa simplex (EBS). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(4), 640.
  
• The role of collagen XVII in ras-driven human epidermal tumorigenesis Makino, T., Ngyun, N. T., Chen, C. H., Shimizu, T., Rizzo, A. C., & Marinkovich, M. P. (2007). The role of collagen XVII in ras-driven human epidermal tumorigenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127, S24.
  
• Role of tyrosine kinase in endothelial cell migration and angiogenesis Zhou, L., Marinkovich, M., & Karasek, M. (2001). Role of tyrosine kinase in endothelial cell migration and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 392.
  
• Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using EB-101 (COL7A1 gene-corrected autologous keratinocytes) Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Dutt-Singkh, Y., Nazaroff, J., … Marinkovich, M. P. (2017). Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using EB-101 (COL7A1 gene-corrected autologous keratinocytes). HUMAN GENE THERAPY, 28(12), A10.
  
• Integrin alpha 6 beta 4 ligation controls keratinocyte morphology and chemotaxis through opposing stimulation of the small GTPases, Rac and Rho Russell, A., Fincher, E., Vela, Smith, R., & Marinkovich, M. (2001). Integrin alpha 6 beta 4 ligation controls keratinocyte morphology and chemotaxis through opposing stimulation of the small GTPases, Rac and Rho. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 477.
  
• Phase 1 clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa Siprashvili, Z., Nguyen, N. T., Gorell, E., Khuu, P., Furukawa, L., Lorenz, H. P., … Lane, A. T. (2014). Phase 1 clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, S75.
  
• Deletion of dermal integrin beta-1 leads to adhesion, but not hair follicle morphogenesis, defects DeRouen, M. C., Marinkovich, M. P., & Oro, A. E. (2010). Deletion of dermal integrin beta-1 leads to adhesion, but not hair follicle morphogenesis, defects. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130, S104.
  
• Phenotypic reversion of alpha 3-deficient human keratinocytes and functional studies of laminin 5 Fincher, E. F., Russell, A. J., & Marinkovich, M. P. (2000). Phenotypic reversion of alpha 3-deficient human keratinocytes and functional studies of laminin 5. MOLECULAR BIOLOGY OF THE CELL, 11, 391A–392A.
  
• Role of laminin-10 in hair development Gao, J., Chen, C., Nguyen, N. T., Leopold, P. L., Crystal, R. G., Miner, J. H., … Marinkovich, M. P. (2004). Role of laminin-10 in hair development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A112.
  
• Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015 Choi, S., Solis, D., Nazaroff, J., Bailey-Healy, I., Barriga, M., Dutt-Singkh, Y., … Tang, J. Y. (2017). Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S38.
  
• Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa Solis, D., Nazaroff, J., Dutt-Singkh, Y., Choi, S., Barriga, M., Bailey-Healy, I., … Tang, J. Y. (2017). Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S37.
  
• Molecular mechanisms of hypoxia-driven keratinocyte motility OToole, E. A., Peavey, C., Marinkovich, M. P., Furthmayr, H., Mustoe, T., & Woodley, D. T. (1996). Molecular mechanisms of hypoxia-driven keratinocyte motility. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 141.
  
• CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES Koller, M., Flanagan, K., Skov, M., Goldblum, R., Griffith, S. G., Barbour, R. M., … Ness, D. (2016). CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES. ANNALS OF THE RHEUMATIC DISEASES, 75, 134.
  
• NC1 domain of type VII (anchoring fibril) collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. Chen, M., Marinkovich, M. P., Jones, J. C., O'Toole, E. A., Li, Y. Y., & Woodley, D. T. (1998). NC1 domain of type VII (anchoring fibril) collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 110(4), 496.
  
• A novel therapeutic inhibits Rac1 mediated invasion and metastasis in a newly described in vivo model of human melanoma Winge, M. C., Kovalski, J., Nguyen, N. T., Wu, D., Zehnder, A., Khavari, P., & Marinkovich, M. (2015). A novel therapeutic inhibits Rac1 mediated invasion and metastasis in a newly described in vivo model of human melanoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135, S71.
  
• Attenuated netrin-1 receptor mediated regulation of tiam1 is required for rac1 mutant melanoma progression Winge, M. C. G., Kovalski, J., Nguyen, N. T., Wu, D., Zehnder, A., Khavari, P. A., & Marinkovich, M. (2017). Attenuated netrin-1 receptor mediated regulation of tiam1 is required for rac1 mutant melanoma progression. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S139.
  
• Laminin 10 in wound re-epithelialization and angiogenesis Li, J., Kirsner, R. S., Marinkovich, M. P., Miner, J. H., & Zhang, Y. (2002). Laminin 10 in wound re-epithelialization and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 233.
  
• LAMININ-5 INHIBITS KERATINOCYTE MOTILITY OTOOLE, E. A., MARINKOVICH, M. P., YURKO, M. A., & WOODLEY, D. T. (1995). LAMININ-5 INHIBITS KERATINOCYTE MOTILITY. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(6), 871.
  
• Loss of the laminin-332 alpha 3IIIa domain impairs keratinocyte migration in vitro Wang, J. Y., Lakshmireddy, H. K. D., & Marinkovich, M. P. (2014). Loss of the laminin-332 alpha 3IIIa domain impairs keratinocyte migration in vitro. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, S87.
  
• Laminin/Integrin expression profile in malignant melanoma Wong, K., Marinkovich, M. P., & Horst, B. A. (2008). Laminin/Integrin expression profile in malignant melanoma. MODERN PATHOLOGY, 21, 103A–104A.
  
• ITK and RLK inhibitor improves skin disease in a psoriatic mouse model Fuhriman, J. M., Winge, M. C. G., Haberstock-Debic, H., Funk, J. O., Bradshaw, M., & Marinkovich, M. (2017). ITK and RLK inhibitor improves skin disease in a psoriatic mouse model. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S120.
  
• Laminin 10 in the angiogenesis and invasion of squamous cell carcinoma Li, J., Zhang, Y., Romagosa, R., Saghari, S., Elgart, G., Miner, J. H., … Nouri, K. (2005). Laminin 10 in the angiogenesis and invasion of squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A21.
  
• Targeting pathogenic interactions between Rac1 and NCK1 in psoriasis Winge, M. C. G., Nasrallah, M., Fuhriman, J. M., Ramanathan, M., Azameera, A., Nguyen, N., … Marinkovich, M. (2018). Targeting pathogenic interactions between Rac1 and NCK1 in psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S161.
  
• Successful in vivo COL7A1 gene delivery and correction of recessive dystrophic epidermolysis bullosa (RDEB) skin using an off the shelf HSV-1 vector (KB103) Gurevich, I., Agarwal, P., Dolorito, J., Prisco, M., O'Malley, M., Regula, L., … Marinkovich, M. (2018). Successful in vivo COL7A1 gene delivery and correction of recessive dystrophic epidermolysis bullosa (RDEB) skin using an off the shelf HSV-1 vector (KB103). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S129.
  
• Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment Solis, D., Nazaroff, J., Dutt-Singkh, Y., Choi, S., Barriga, M., Li, S., … Tang, J. (2018). Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S97.
  
• Measurement of skin adherence in recessive dystrophic epidermolysis bullosa patients Nazaroff, J., Li, S., Lane, A., Marinkovich, M., & Tang, J. (2018). Measurement of skin adherence in recessive dystrophic epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S102.
  
• 50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durability Dutt-Singkh, Y., Barriga, M., Nazaroff, J., Solis, D., Li, S., Marinkovich, M., & Tang, J. (2018). 50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durability. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S56.
  
• A phase 1/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB) Marinkovich, M., Lane, A., Sridhar, K., Keene, D., Malyala, A., & Maslowski, J. (2018). A phase 1/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S100.
  
• A new deletion mutation sheds light on laminin-332 biology. Marinkovich, M. P. (2018). A new deletion mutation sheds light on laminin-332 biology. The British Journal of Dermatology, 178(6), 1245.
  
• CyTOF analysis allows characterization of Axl-Expressing Dendritic cells in healthy human donors Leylek, R., Alcantara-Hernandez, M., Wagar, L. E., Engleman, E. G., Marinkovich, M. P., Davis, M. M., … Idoyaga, J. (2018). CyTOF analysis allows characterization of Axl-Expressing Dendritic cells in healthy human donors. EUROPEAN JOURNAL OF IMMUNOLOGY, 48, 29.
  
• A high-dimensional phenotypic map of human Dendritic cells paves the way for therapeutics Alcantara-Hernandez, M., Leylek, R., Wagar, L. E., Engleman, E. G., Keler, T., Marinkovich, M. P., … Idoyaga, J. (2018). A high-dimensional phenotypic map of human Dendritic cells paves the way for therapeutics. EUROPEAN JOURNAL OF IMMUNOLOGY, 48, 25–26.
  
• Phase I / II Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using EB-101 (COL7A1 Gene-Corrected Autologous Keratinocytes) Tang, J. Y., Marinkovich, M. P., Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., … Lane, A. T. (2018). Phase I / II Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using EB-101 (COL7A1 Gene-Corrected Autologous Keratinocytes). MOLECULAR THERAPY, 26(5), 158.
  
• Measurement of Skin Adhesion in Recessive Dystrophic Epidermolysis Bullosa Patients. Nazaroff, J., Manoukian, M., Barriga, M., Lane, A., Marinkovich, M. P., & Tang, J. Y. (2018). Measurement of Skin Adhesion in Recessive Dystrophic Epidermolysis Bullosa Patients. Journal of the American Academy of Dermatology.
  
• Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. Murrell, D. F., Pena, S., Joly, P., Marinovic, B., Hashimoto, T., Diaz, L. A., … Werth, V. P. (2018). Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology.
  
• Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. Baumer, Y., Ng, Q., Sanda, G. E., Dey, A. K., Teague, H. L., Sorokin, A. V., … Mehta, N. N. (2018). Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. JCI Insight, 3(1).
  
• A new deletion mutation sheds light on laminin-332 biology Marinkovich, M. P. (2018). A new deletion mutation sheds light on laminin-332 biology. BRITISH JOURNAL OF DERMATOLOGY, 178(6), 1245.
  
• ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis Fuhriman, J. M., Winge, M. C. G., Haberstock-Debic, H., Funk, J. O., Bradshaw, J. M., & Marinkovich, M. P. (2018). ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(4), 864–71.
  
• Gene Therapy for Epidermolysis Bullosa. Marinkovich, M. P., & Tang, J. Y. (2019). Gene Therapy for Epidermolysis Bullosa. The Journal of Investigative Dermatology.
  
• Genetically corrected autologous keratinocyte epidermal grafts improve wound healing and patient reported outcomes in patients with recessive dystrophic epidermolysis bullosa Eichstadt, S., Barriga, M., Teng, C., Nguyen, N. T., Gorell, E., Siprashvili, Z., … Tang, J. (2019). Genetically corrected autologous keratinocyte epidermal grafts improve wound healing and patient reported outcomes in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S64.
  
• Natural history of wounds in patients with recessive dystrophic epidermolysis bullosa Teng, C., Solis, D., Tang, J., Barriga, M., & Marinkovich, M. P. (2019). Natural history of wounds in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S43.
  
• The use of human skin equivalents to evaluate the effectivity of QR-313, an antisense oligonucleotide, in gel formulation Hogervorst, M., van Berkel, M., Oort, C., Marinkovich, M. P., Keene, D., Ritsema, T., … Haisma, I. (2019). The use of human skin equivalents to evaluate the effectivity of QR-313, an antisense oligonucleotide, in gel formulation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S64.
  
• First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial Marinkovich, M. P., Sridhar, K., Gurevich, I., Ponakala, A., Boddu, S., Keene, D., … Krishnan, S. (2019). First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S66.
  
• Gene Therapy for Epidermolysis Bullosa Marinkovich, M. P., & Tang, J. Y. (2019). Gene Therapy for Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(6), 1221–26.
  
• Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N. T., Siprashvili, Z., … Tang, J. Y. (2019). Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight, 4(19).
  
• Epidermolysis bullosa with pyloric atresia consistently demonstrates concurrent low intra-basal epidermal and lamina lucida cleavage planes: a survey of six cases. Wang, J. Y., Marinkovich, M. P., & Rieger, K. E. (2019). Epidermolysis bullosa with pyloric atresia consistently demonstrates concurrent low intra-basal epidermal and lamina lucida cleavage planes: a survey of six cases. Journal of the European Academy of Dermatology and Venereology : JEADV.
  
• From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB) Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (2019). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 12, 933–42.
  
• Diagnosis and management of pemphigus: Recommendations of an international panel of experts Murrell, D. F., Pena, S., Joly, P., Marinovic, B., Hashimoto, T., Diaz, L. A., … Werth, V. P. (2020). Diagnosis and management of pemphigus: Recommendations of an international panel of experts. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 82(3), 575-+.
  
• Patient Reported Outcomes and Quality of Life in Recessive Dystrophic Epidermolysis Bullosa: A Global Cross-sectional Survey. Eng, V. A., Solis, D. C., Gorell, E. S., Choi, S., Nazaroff, J., Li, S., … Tang, J. Y. (2020). Patient Reported Outcomes and Quality of Life in Recessive Dystrophic Epidermolysis Bullosa: A Global Cross-sectional Survey. Journal of the American Academy of Dermatology.
  
• Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Has, C., Bauer, J. W., Bodemer, C., Bolling, M. C., Bruckner-Tuderman, L., Diem, A., … Mellerio, J. E. (2020). Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. The British Journal of Dermatology.
  
• Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts. Murrell, D. F., Lucky, A. W., Salas-Alanis, J. C., Woodley, D. T., Palisson, F., Natsuga, K., … Martinez, A. E. (2020). Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology.
  
• Neutrophils are critical in linear IgA bullous dermatosis in mice Li, N., Burette, S., Jing, K., Mulligan, E., Yanik, J., Yang, B., … Liu, Z. (2020). Neutrophils are critical in linear IgA bullous dermatosis in mice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S10.
  
• Type VII collagen NC2 domain expression differentiates severe from milder recessive dystrophic epidermolysis bullosa subtypes Ponakala, A., Yenamandra, V. K., Teng, C. E., Barriga, M., Dolorito, J., Gorell, E., … Marinkovich, M. P. (2020). Type VII collagen NC2 domain expression differentiates severe from milder recessive dystrophic epidermolysis bullosa subtypes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
  
• Premature thymic involution and oropharyngeal blistering cause early lethality in generalized severe junctional epidermolysis bullosa Yenamandra, V. K., Dolorito, J., Gurevitch, I., Godoy, E., Casey, K., & Marinkovich, M. P. (2020). Premature thymic involution and oropharyngeal blistering cause early lethality in generalized severe junctional epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S35.
  
• Topical QR-313, an Antisense Oligonucleotide, in the Treatment of Dystrophic Epidermolysis Bullosa Marinkovich, M. P., Sridhar, K., Karkala, V., Yenamandra, V. K., Gurevitch, I., Dolorito, J., … Landy, H. (2020). Topical QR-313, an Antisense Oligonucleotide, in the Treatment of Dystrophic Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
  
• In vivo correction of recessive dystrophic epidermolysis bullosa (RDEB) by direct cutaneous COL7A1 gene replacement: Results of a phase 1-2 trial Marinkovich, M. P., Vinzant, S., Karkala, V., Sridhar, K., Gurevitch, I., Dolorito, J., … Krishnan, S. (2020). In vivo correction of recessive dystrophic epidermolysis bullosa (RDEB) by direct cutaneous COL7A1 gene replacement: Results of a phase 1-2 trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
  
• Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey Gorell, E., Eng, V., Solis, D., Choi, S., Nazaroff, J., Li, S., … Tang, J. (2020). Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S34.
  
• Classification of Two Distinct Wound Types in Recessive Dystrophic Epidermolysis Bullosa: A Retrospective and Cohort Natural History Study. Solis, D. C., Teng, C., Gorell, E. S., Barriga, M., Nazaroff, J., Li, S., … Tang, J. Y. (2020). Classification of Two Distinct Wound Types in Recessive Dystrophic Epidermolysis Bullosa: A Retrospective and Cohort Natural History Study. Journal of the American Academy of Dermatology.
  
• Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa. Fuentes, I., Guttmann-Gruber, C., Tockner, B., Diem, A., Klausegger, A., Cofré-Araneda, G., … South, A. P. (2020). Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa. Scientific Reports, 10(1), 15064.
  
• QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study. Bornert, O., Hogervorst, M., Nauroy, P., Bischof, J., Swildens, J., Athanasiou, I., … Nystrom, A. (2020). QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study. The Journal of Investigative Dermatology.